We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
iShares Russell 2000 Value ETF
IWN
$14.6B
| $896K | ﹤0.01% |
5,592
+3,452
| +161% | +$555K |
|
2277
Ocular Therapeutix
OCUL
$2.02B
| $890K | ﹤0.01% |
88,962
+3,845
| +5% | +$43.2K |
|
2278
Alphatec Holdings
ATEC
$1.44B
| $889K | ﹤0.01% |
72,899
+2,820
| +4% | +$39.3K |
|
2279
Stoneridge
SRI
$213M
| $884K | ﹤0.01% |
43,342
+1,225
| +3% | +$30.3K |
|
2280
CNA Financial
CNA
$14.1B
| $883K | ﹤0.01% |
21,039
-1,987
| -9% | -$86.8K |
|
2281
Sterling Infrastructure
STRL
$16.7B
| $883K | ﹤0.01% |
38,955
+1,237
| +3% | +$27.6K |
|
|
TSC
2282
DELISTED
TriState Capital Holdings, Inc.
TSC
| $883K | ﹤0.01% |
41,765
+940
| +2% | +$19K |
|
|
SPPI
2283
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $882K | ﹤0.01% |
404,538
-46,012
| -10% | -$126K |
|
2284
Rackspace Technology
RXT
$1.24B
| $881K | ﹤0.01% |
61,986
+2,476
| +4% | +$39.8K |
|
2285
Titan International
TWI
$475M
| $881K | ﹤0.01% |
123,099
-19,016
| -13% | -$150K |
|
2286
iShares Russell 3000 ETF
IWV
$20.4B
| $880K | ﹤0.01% |
+3,453
| New | +$904K |
|
2287
Metropolitan Bank Holding Corp
MCB
$1.15B
| $880K | ﹤0.01% |
10,436
+375
| +4% | +$27.3K |
|
2288
Rush Street Interactive
RSI
$2.88B
| $878K | ﹤0.01% |
45,698
+5,539
| +14% | +$75.8K |
|
2289
Red Robin
RRGB
$152M
| $877K | ﹤0.01% |
38,025
-6,163
| -14% | -$159K |
|
2290
Mitek Systems
MITK
$834M
| $876K | ﹤0.01% |
47,368
+1,924
| +4% | +$39K |
|
|
CAMP
2291
DELISTED
CalAmp Corp.
CAMP
| $875K | ﹤0.01% |
3,825
-576
| -13% | -$152K |
|
|
TTCF
2292
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $875K | ﹤0.01% |
47,471
+2,140
| +5% | +$42.3K |
|
|
FRTA
2293
DELISTED
Forterra, Inc
FRTA
| $870K | ﹤0.01% |
36,940
+3,907
| +12% | +$92K |
|
2294
CRA International
CRAI
$1.06B
| $860K | ﹤0.01% |
8,653
+260
| +3% | +$23.5K |
|
2295
Green Brick Partners
GRBK
$3.14B
| $859K | ﹤0.01% |
41,882
+1,055
| +3% | +$24.9K |
|
2296
OrthoPediatrics
KIDS
$595M
| $859K | ﹤0.01% |
13,107
+569
| +5% | +$37K |
|
2297
Citi Trends
CTRN
$605M
| $857K | ﹤0.01% |
11,749
+255
| +2% | +$20.4K |
|
2298
Fulcrum Therapeutics
FULC
$297M
| $852K | ﹤0.01% |
30,199
+7,724
| +34% | +$146K |
|
|
SPNS
2299
DELISTED
Sapiens International
SPNS
| $851K | ﹤0.01% |
29,579
+1,425
| +5% | +$39K |
|
2300
Arcutis Biotherapeutics
ARQT
$3.18B
| $850K | ﹤0.01% |
35,584
+1,300
| +4% | +$29.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.